A prospective trial of stereotactic body radiation therapy for unresectable pancreatic cancer testing ablative doses.

Liauw, Stanley L; Ni, Lisa; Wu, Tianming; Arif, Fauzia; Cloutier, Denise; Posner, Mitchell C; Kozloff, Mark; Kindler, Hedy L

Liauw, Stanley L; Ni, Lisa; Wu, Tianming; Arif, Fauzia; Cloutier, Denise; Posner, Mitchell C; Kozloff, Mark; Kindler, Hedy L.

Afiliación

Liauw SL; Department of Radiation Oncology, University of Chicago Medical Center, Chicago, IL, USA.
Ni L; Department of Radiation Oncology, University of Chicago Medical Center, Chicago, IL, USA.
Wu T; Department of Radiation Oncology, University of Chicago Medical Center, Chicago, IL, USA.
Arif F; Department of Radiation Oncology, University of Chicago Medical Center, Chicago, IL, USA.
Cloutier D; Department of Radiation Oncology, University of Chicago Medical Center, Chicago, IL, USA.
Posner MC; Department of Surgical Oncology, University of Chicago Medical Center, Chicago, IL, USA.
Kozloff M; Department of Medical Oncology, University of Chicago Medical Center, Chicago, IL, USA.
Kindler HL; Department of Medical Oncology, University of Chicago Medical Center, Chicago, IL, USA.

J Gastrointest Oncol ; 11(6): 1399-1407, 2020 Dec.

Article en En | MEDLINE | ID: mdl-33457009

Palabras clave

Pancreatic cancer; radiation therapy (RT); stereotactic body radiation therapy (SBRT)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Risk_factors_studies Idioma: En Revista: J Gastrointest Oncol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google